Holliston, MA 12/4/13—Scientific instrument and apparatus company Harvard Bioscience will trim its workforce by 13% as part of a realignment of global operations. The reductions will eliminate certain operational redundancies and create a leaner, more nimble organization, according to the company. Beginning in 2014, the company expects to record annual savings of around $2 million on a pre-tax basis. “We will also be focusing on increasing growth, expanding in Asia and other emerging markets, building stronger channel capabilities and reinvigorating product development. We are implementing several initiatives aimed at driving efficiencies and improving our operational and cost structure,” said Harvard Bioscience President and CEO Jeffrey A. Duchemin. Out of an immediate reduction of around $3 million in personnel-related costs, around $1 million will be reinvested.